Todd J. Anderson

Richard Leigh3
Matthias G Friedrich2
3Richard Leigh
2Matthias G Friedrich
1Sara E. Hartmann
Learn More
  • Amanda V Tyndall, Margie H Davenport, Ben J Wilson, Grazyna M Burek, Genevieve Arsenault-Lapierre, Eryka Haley +9 others
  • 2013
BACKGROUND Aging and physical inactivity are associated with declines in some cognitive domains and cerebrovascular function, as well as an elevated risk of cerebrovascular disease and other morbidities. With the increase in the number of sedentary older Canadians, promoting healthy brain aging is becoming an increasingly important population health issue.(More)
BACKGROUND New guidelines for cardiovascular disease risk assessment and statin eligibility have recently been published in the United States by the American College of Cardiology and the American Heart Association (ACC-AHA). It is unknown how these guidelines compare with the Canadian Cardiovascular Society (CCS) recommendations. METHODS AND RESULTS(More)
BACKGROUND Nationally, symptomatic heart failure affects 1.5-2% of Canadians, incurs $3 billion in hospital costs annually and the global burden is expected to double in the next 1-2 decades. The current one-year mortality rate after diagnosis of heart failure remains high at >25%. Consequently, new therapeutic strategies need to be developed for this(More)
  • Matthew D. Spencer, Amanda V. Tyndall, Margie H. Davenport, Laurie Argourd, Todd J. Anderson, Gail A. Eskes +9 others
  • 2015
The primary purpose of this Brain in Motion (BIM) sub-study was to determine the 6-month stability of resting blood flow velocity and cerebrovascular responsiveness to a euoxic hypercapnic challenge in a group of physically inactive community dwelling men and men aged ≥55 yrs (range 55-92 yrs). At baseline and 6 months later 88 women (65±6 yr) and 78 men(More)
BACKGROUND Schizophrenia is a mental illness associated with cardiovascular disease at a younger age than in the general population. Endothelial dysfunction has predictive value for future cardiovascular events; however, the impact of a diagnosis of schizophrenia on this marker is unknown. AIMS We tested the hypothesis that subjects with schizophrenia(More)
BACKGROUND Clinical manifestations and outcomes of atherosclerotic disease differ between ethnic groups. In addition, the prevalence of risk factors is substantially different. Primary prevention programs are based on data derived from almost exclusively White people. We investigated how race/ethnic differences modify the associations of established risk(More)
  • 1